ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Precision Cancer Medicine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-35A15351
Home | Market Reports | Health| Health Conditions| Cancer
Global Precision Cancer Medicine Market Research Report 2023
BUY CHAPTERS

Global Precision Cancer Medicine Market Research Report 2025

Code: QYRE-Auto-35A15351
Report
May 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol–Myers Squibb
Amgen Inc
Astrazeneca plc
Merck
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer Inc
GSK
Exelixis Inc
Regeneron
Innovent
Hengrui Medicine

Precision Cancer Medicine Market Size

The global market for Precision Cancer Medicine was valued at US$ 192390 million in the year 2024 and is projected to reach a revised size of US$ 433640 million by 2031, growing at a CAGR of 12.5% during the forecast period.

Precision Cancer Medicine Market

Precision Cancer Medicine Market

Precision cancer medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient"s cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient"s tumor.
Precision cancer medicine, also known as personalized or targeted cancer therapy, is driven by the growing understanding of cancer"s molecular and genetic complexity. Advances in genomics and biomarker identification have enabled the development of therapies tailored to an individual"s specific cancer characteristics. This approach offers the potential for more effective treatments with fewer side effects compared to traditional chemotherapy. The market benefits from increasing research in oncology, the rise of precision diagnostics, and the growing availability of targeted therapies. However, challenges include the high cost of genetic testing and targeted treatments, as well as the need for comprehensive molecular profiling. Additionally, regulatory approvals and insurance coverage for these therapies can be complex. To maximize the potential of precision cancer medicine, stakeholders must address these challenges, improve accessibility, and continue research into novel biomarkers and therapies to provide tailored cancer care for patients.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Medicine.
The Precision Cancer Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Precision Cancer Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Cancer Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Precision Cancer Medicine Market Report

Report Metric Details
Report Name Precision Cancer Medicine Market
Accounted market size in year US$ 192390 million
Forecasted market size in 2031 US$ 433640 million
CAGR 12.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Precision Cancer Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Precision Cancer Medicine Market growing?

Ans: The Precision Cancer Medicine Market witnessing a CAGR of 12.5% during the forecast period 2025-2031.

What is the Precision Cancer Medicine Market size in 2031?

Ans: The Precision Cancer Medicine Market size in 2031 will be US$ 433640 million.

Who are the main players in the Precision Cancer Medicine Market report?

Ans: The main players in the Precision Cancer Medicine Market are AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine

What are the Application segmentation covered in the Precision Cancer Medicine Market report?

Ans: The Applications covered in the Precision Cancer Medicine Market report are Lung Cancer, Breast Cancer, Prostate Cancer, Blood-related Cancer, Other

What are the Type segmentation covered in the Precision Cancer Medicine Market report?

Ans: The Types covered in the Precision Cancer Medicine Market report are Cancer Immunotherapy, Targeted Therapy

Recommended Reports

Precision Medicine

Cancer Diagnostics

Targeted Cancer Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cancer Immunotherapy
1.2.3 Targeted Therapy
1.3 Market by Application
1.3.1 Global Precision Cancer Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Prostate Cancer
1.3.5 Blood-related Cancer
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Medicine Market Perspective (2020-2031)
2.2 Global Precision Cancer Medicine Growth Trends by Region
2.2.1 Global Precision Cancer Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Precision Cancer Medicine Historic Market Size by Region (2020-2025)
2.2.3 Precision Cancer Medicine Forecasted Market Size by Region (2026-2031)
2.3 Precision Cancer Medicine Market Dynamics
2.3.1 Precision Cancer Medicine Industry Trends
2.3.2 Precision Cancer Medicine Market Drivers
2.3.3 Precision Cancer Medicine Market Challenges
2.3.4 Precision Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Medicine Players by Revenue
3.1.1 Global Top Precision Cancer Medicine Players by Revenue (2020-2025)
3.1.2 Global Precision Cancer Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Precision Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Precision Cancer Medicine Revenue
3.4 Global Precision Cancer Medicine Market Concentration Ratio
3.4.1 Global Precision Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Medicine Revenue in 2024
3.5 Global Key Players of Precision Cancer Medicine Head office and Area Served
3.6 Global Key Players of Precision Cancer Medicine, Product and Application
3.7 Global Key Players of Precision Cancer Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Medicine Breakdown Data by Type
4.1 Global Precision Cancer Medicine Historic Market Size by Type (2020-2025)
4.2 Global Precision Cancer Medicine Forecasted Market Size by Type (2026-2031)
5 Precision Cancer Medicine Breakdown Data by Application
5.1 Global Precision Cancer Medicine Historic Market Size by Application (2020-2025)
5.2 Global Precision Cancer Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Precision Cancer Medicine Market Size (2020-2031)
6.2 North America Precision Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Precision Cancer Medicine Market Size by Country (2020-2025)
6.4 North America Precision Cancer Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Cancer Medicine Market Size (2020-2031)
7.2 Europe Precision Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Precision Cancer Medicine Market Size by Country (2020-2025)
7.4 Europe Precision Cancer Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Medicine Market Size (2020-2031)
8.2 Asia-Pacific Precision Cancer Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Precision Cancer Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Precision Cancer Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Cancer Medicine Market Size (2020-2031)
9.2 Latin America Precision Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Precision Cancer Medicine Market Size by Country (2020-2025)
9.4 Latin America Precision Cancer Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Medicine Market Size (2020-2031)
10.2 Middle East & Africa Precision Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Precision Cancer Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Precision Cancer Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Precision Cancer Medicine Introduction
11.1.4 AbbVie Revenue in Precision Cancer Medicine Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Precision Cancer Medicine Introduction
11.2.4 Johnson & Johnson Revenue in Precision Cancer Medicine Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Precision Cancer Medicine Introduction
11.3.4 Novartis Revenue in Precision Cancer Medicine Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Precision Cancer Medicine Introduction
11.4.4 Gilead Sciences Revenue in Precision Cancer Medicine Business (2020-2025)
11.4.5 Gilead Sciences Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Precision Cancer Medicine Introduction
11.5.4 Roche Revenue in Precision Cancer Medicine Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Precision Cancer Medicine Introduction
11.6.4 Bristol-Myers Squibb Revenue in Precision Cancer Medicine Business (2020-2025)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Precision Cancer Medicine Introduction
11.7.4 Amgen Revenue in Precision Cancer Medicine Business (2020-2025)
11.7.5 Amgen Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Precision Cancer Medicine Introduction
11.8.4 AstraZeneca Revenue in Precision Cancer Medicine Business (2020-2025)
11.8.5 AstraZeneca Recent Development
11.9 Merck & Co
11.9.1 Merck & Co Company Details
11.9.2 Merck & Co Business Overview
11.9.3 Merck & Co Precision Cancer Medicine Introduction
11.9.4 Merck & Co Revenue in Precision Cancer Medicine Business (2020-2025)
11.9.5 Merck & Co Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Precision Cancer Medicine Introduction
11.10.4 Takeda Revenue in Precision Cancer Medicine Business (2020-2025)
11.10.5 Takeda Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Precision Cancer Medicine Introduction
11.11.4 Merck KGaA Revenue in Precision Cancer Medicine Business (2020-2025)
11.11.5 Merck KGaA Recent Development
11.12 Seagen
11.12.1 Seagen Company Details
11.12.2 Seagen Business Overview
11.12.3 Seagen Precision Cancer Medicine Introduction
11.12.4 Seagen Revenue in Precision Cancer Medicine Business (2020-2025)
11.12.5 Seagen Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Precision Cancer Medicine Introduction
11.13.4 Eli Lilly Revenue in Precision Cancer Medicine Business (2020-2025)
11.13.5 Eli Lilly Recent Development
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Details
11.14.2 Ono Pharmaceutical Business Overview
11.14.3 Ono Pharmaceutical Precision Cancer Medicine Introduction
11.14.4 Ono Pharmaceutical Revenue in Precision Cancer Medicine Business (2020-2025)
11.14.5 Ono Pharmaceutical Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Precision Cancer Medicine Introduction
11.15.4 Pfizer Revenue in Precision Cancer Medicine Business (2020-2025)
11.15.5 Pfizer Recent Development
11.16 GSK
11.16.1 GSK Company Details
11.16.2 GSK Business Overview
11.16.3 GSK Precision Cancer Medicine Introduction
11.16.4 GSK Revenue in Precision Cancer Medicine Business (2020-2025)
11.16.5 GSK Recent Development
11.17 Exelixis
11.17.1 Exelixis Company Details
11.17.2 Exelixis Business Overview
11.17.3 Exelixis Precision Cancer Medicine Introduction
11.17.4 Exelixis Revenue in Precision Cancer Medicine Business (2020-2025)
11.17.5 Exelixis Recent Development
11.18 Regeneron
11.18.1 Regeneron Company Details
11.18.2 Regeneron Business Overview
11.18.3 Regeneron Precision Cancer Medicine Introduction
11.18.4 Regeneron Revenue in Precision Cancer Medicine Business (2020-2025)
11.18.5 Regeneron Recent Development
11.19 Innovent
11.19.1 Innovent Company Details
11.19.2 Innovent Business Overview
11.19.3 Innovent Precision Cancer Medicine Introduction
11.19.4 Innovent Revenue in Precision Cancer Medicine Business (2020-2025)
11.19.5 Innovent Recent Development
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Details
11.20.2 Hengrui Medicine Business Overview
11.20.3 Hengrui Medicine Precision Cancer Medicine Introduction
11.20.4 Hengrui Medicine Revenue in Precision Cancer Medicine Business (2020-2025)
11.20.5 Hengrui Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol–Myers Squibb
Amgen Inc
Astrazeneca plc
Merck
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer Inc
GSK
Exelixis Inc
Regeneron
Innovent
Hengrui Medicine
List of Tables
 Table 1. Global Precision Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cancer Immunotherapy
 Table 3. Key Players of Targeted Therapy
 Table 4. Global Precision Cancer Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Precision Cancer Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Precision Cancer Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Precision Cancer Medicine Market Share by Region (2020-2025)
 Table 8. Global Precision Cancer Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Precision Cancer Medicine Market Share by Region (2026-2031)
 Table 10. Precision Cancer Medicine Market Trends
 Table 11. Precision Cancer Medicine Market Drivers
 Table 12. Precision Cancer Medicine Market Challenges
 Table 13. Precision Cancer Medicine Market Restraints
 Table 14. Global Precision Cancer Medicine Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Precision Cancer Medicine Market Share by Players (2020-2025)
 Table 16. Global Top Precision Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Medicine as of 2024)
 Table 17. Ranking of Global Top Precision Cancer Medicine Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Precision Cancer Medicine Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Precision Cancer Medicine, Headquarters and Area Served
 Table 20. Global Key Players of Precision Cancer Medicine, Product and Application
 Table 21. Global Key Players of Precision Cancer Medicine, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Precision Cancer Medicine Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Precision Cancer Medicine Revenue Market Share by Type (2020-2025)
 Table 25. Global Precision Cancer Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Precision Cancer Medicine Revenue Market Share by Type (2026-2031)
 Table 27. Global Precision Cancer Medicine Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Precision Cancer Medicine Revenue Market Share by Application (2020-2025)
 Table 29. Global Precision Cancer Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Precision Cancer Medicine Revenue Market Share by Application (2026-2031)
 Table 31. North America Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Precision Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Precision Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Precision Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Precision Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Precision Cancer Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Precision Cancer Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Precision Cancer Medicine Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Precision Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Precision Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Precision Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Precision Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 46. AbbVie Company Details
 Table 47. AbbVie Business Overview
 Table 48. AbbVie Precision Cancer Medicine Product
 Table 49. AbbVie Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 50. AbbVie Recent Development
 Table 51. Johnson & Johnson Company Details
 Table 52. Johnson & Johnson Business Overview
 Table 53. Johnson & Johnson Precision Cancer Medicine Product
 Table 54. Johnson & Johnson Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 55. Johnson & Johnson Recent Development
 Table 56. Novartis Company Details
 Table 57. Novartis Business Overview
 Table 58. Novartis Precision Cancer Medicine Product
 Table 59. Novartis Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 60. Novartis Recent Development
 Table 61. Gilead Sciences Company Details
 Table 62. Gilead Sciences Business Overview
 Table 63. Gilead Sciences Precision Cancer Medicine Product
 Table 64. Gilead Sciences Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 65. Gilead Sciences Recent Development
 Table 66. Roche Company Details
 Table 67. Roche Business Overview
 Table 68. Roche Precision Cancer Medicine Product
 Table 69. Roche Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 70. Roche Recent Development
 Table 71. Bristol-Myers Squibb Company Details
 Table 72. Bristol-Myers Squibb Business Overview
 Table 73. Bristol-Myers Squibb Precision Cancer Medicine Product
 Table 74. Bristol-Myers Squibb Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 75. Bristol-Myers Squibb Recent Development
 Table 76. Amgen Company Details
 Table 77. Amgen Business Overview
 Table 78. Amgen Precision Cancer Medicine Product
 Table 79. Amgen Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 80. Amgen Recent Development
 Table 81. AstraZeneca Company Details
 Table 82. AstraZeneca Business Overview
 Table 83. AstraZeneca Precision Cancer Medicine Product
 Table 84. AstraZeneca Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 85. AstraZeneca Recent Development
 Table 86. Merck & Co Company Details
 Table 87. Merck & Co Business Overview
 Table 88. Merck & Co Precision Cancer Medicine Product
 Table 89. Merck & Co Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 90. Merck & Co Recent Development
 Table 91. Takeda Company Details
 Table 92. Takeda Business Overview
 Table 93. Takeda Precision Cancer Medicine Product
 Table 94. Takeda Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 95. Takeda Recent Development
 Table 96. Merck KGaA Company Details
 Table 97. Merck KGaA Business Overview
 Table 98. Merck KGaA Precision Cancer Medicine Product
 Table 99. Merck KGaA Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 100. Merck KGaA Recent Development
 Table 101. Seagen Company Details
 Table 102. Seagen Business Overview
 Table 103. Seagen Precision Cancer Medicine Product
 Table 104. Seagen Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 105. Seagen Recent Development
 Table 106. Eli Lilly Company Details
 Table 107. Eli Lilly Business Overview
 Table 108. Eli Lilly Precision Cancer Medicine Product
 Table 109. Eli Lilly Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 110. Eli Lilly Recent Development
 Table 111. Ono Pharmaceutical Company Details
 Table 112. Ono Pharmaceutical Business Overview
 Table 113. Ono Pharmaceutical Precision Cancer Medicine Product
 Table 114. Ono Pharmaceutical Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 115. Ono Pharmaceutical Recent Development
 Table 116. Pfizer Company Details
 Table 117. Pfizer Business Overview
 Table 118. Pfizer Precision Cancer Medicine Product
 Table 119. Pfizer Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 120. Pfizer Recent Development
 Table 121. GSK Company Details
 Table 122. GSK Business Overview
 Table 123. GSK Precision Cancer Medicine Product
 Table 124. GSK Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 125. GSK Recent Development
 Table 126. Exelixis Company Details
 Table 127. Exelixis Business Overview
 Table 128. Exelixis Precision Cancer Medicine Product
 Table 129. Exelixis Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 130. Exelixis Recent Development
 Table 131. Regeneron Company Details
 Table 132. Regeneron Business Overview
 Table 133. Regeneron Precision Cancer Medicine Product
 Table 134. Regeneron Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 135. Regeneron Recent Development
 Table 136. Innovent Company Details
 Table 137. Innovent Business Overview
 Table 138. Innovent Precision Cancer Medicine Product
 Table 139. Innovent Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 140. Innovent Recent Development
 Table 141. Hengrui Medicine Company Details
 Table 142. Hengrui Medicine Business Overview
 Table 143. Hengrui Medicine Precision Cancer Medicine Product
 Table 144. Hengrui Medicine Revenue in Precision Cancer Medicine Business (2020-2025) & (US$ Million)
 Table 145. Hengrui Medicine Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Precision Cancer Medicine Picture
 Figure 2. Global Precision Cancer Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Precision Cancer Medicine Market Share by Type: 2024 VS 2031
 Figure 4. Cancer Immunotherapy Features
 Figure 5. Targeted Therapy Features
 Figure 6. Global Precision Cancer Medicine Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Precision Cancer Medicine Market Share by Application: 2024 VS 2031
 Figure 8. Lung Cancer Case Studies
 Figure 9. Breast Cancer Case Studies
 Figure 10. Prostate Cancer Case Studies
 Figure 11. Blood-related Cancer Case Studies
 Figure 12. Other Case Studies
 Figure 13. Precision Cancer Medicine Report Years Considered
 Figure 14. Global Precision Cancer Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Precision Cancer Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Precision Cancer Medicine Market Share by Region: 2024 VS 2031
 Figure 17. Global Precision Cancer Medicine Market Share by Players in 2024
 Figure 18. Global Top Precision Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Medicine as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Precision Cancer Medicine Revenue in 2024
 Figure 20. North America Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Precision Cancer Medicine Market Share by Country (2020-2031)
 Figure 22. United States Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Precision Cancer Medicine Market Share by Country (2020-2031)
 Figure 26. Germany Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Precision Cancer Medicine Market Share by Region (2020-2031)
 Figure 34. China Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Precision Cancer Medicine Market Share by Country (2020-2031)
 Figure 42. Mexico Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Precision Cancer Medicine Market Share by Country (2020-2031)
 Figure 46. Turkey Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Precision Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. AbbVie Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 50. Johnson & Johnson Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 51. Novartis Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 52. Gilead Sciences Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 53. Roche Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 55. Amgen Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 56. AstraZeneca Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 57. Merck & Co Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 58. Takeda Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 59. Merck KGaA Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 60. Seagen Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 61. Eli Lilly Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 62. Ono Pharmaceutical Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 63. Pfizer Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 64. GSK Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 65. Exelixis Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 66. Regeneron Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 67. Innovent Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 68. Hengrui Medicine Revenue Growth Rate in Precision Cancer Medicine Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Personalized Cancer Medicine Market Research Report 2025
Global Personalized Precision Medicine Market Research Report 2024
Global Personalized Medicines In Oncology Market Research Report 2024
Global Targeted Chemotherapy Drugs Market Research Report 2024
Artificial Intelligence AI in Precision Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Oncology Drugs Market Research Report 2024
Global Targeted Cancer Therapy Market Research Report 2024
Global Precision Medicine Research and Development Platform Market Research Report 2024
Precision Medicine Diagnostics Market
Global Precision Cancer Tests Market Research Report 2024
Precision Cancer Diagnostic Tests Market
Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Personalized Medicine for Cancer Market Research Report 2025
Precision Cancer Imaging Market
Global Cancer Targeted Drug Market Research Report 2025
Global Non Oncology Precision Medicine Market Research Report 2024
Cancer Treatment Drugs Market
Global Medication Management in Oncology Market Research Report 2025
Global Precision Psychiatry Market Research Report 2024
Global Oncology Small Molecule Drugs Market Insights Forecast to 2030

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions